http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MD-4093-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P23-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
filingDate 2005-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26c20b595046d01c1a01d61824ed5d3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3df462411420cf98731e86d91f0fdc15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c1b7fbe6f649df2083c3733b2459f2a
publicationDate 2011-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MD-4093-B1
titleOfInvention The use of a pharmaceutical composition for topical use containing ambroxol
abstract The invention relates to topical pharmaceutical compositions with local anti-inflammatory and anesthetic properties containing ambroxol. The composition according to the invention contains from 0.1 to 20% ambroxol or one of its pharmaceutically acceptable salts, preferably hydrochloride and is intended for local treatment. of skin pathologies, such as pain, itching, itching, inflammation, mosquito bites and skin hyperemia of allergic, immunological or idiopathic origin.
priorityDate 2004-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000007561-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1200070-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03061642-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009137933-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H10259130-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0546846-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03072094-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009235093-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20030045473-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009019052-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-930011993-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0038653-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9523591-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0240907-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1352646-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2132
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493733
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048

Total number of triples: 48.